4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-24-001974
Options or other derivatives
- Chief Executive Officer acquired 1,545,252 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Collard Craig A · Chief Executive Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-01-19 | Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) | +1,324,502 | 1,324,502 | D |
| 2024-01-19 | Grant or award : show line 2 in the form Restricted Stock Units | +220,750 | 220,750 | D |
Loading xslF345X05/doc4.xml…